|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 126.75 USD | -0.98% |
|
+1.91% | +28.33% |
| 01/09 | Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services | CI |
| 29/08 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| Market Cap | 2.57TCr 2.21TCr 2.08TCr 1.9TCr 3.55TCr 2,42600Cr 3.56TCr 25TCr 9.54TCr 1,24500Cr 9.65TCr 9.44TCr 4,00900Cr | P/E 2026 * |
56.6x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.15TCr 1.85TCr 1.74TCr 1.59TCr 2.97TCr 2,02600Cr 2.98TCr 21TCr 7.97TCr 1,04000Cr 8.06TCr 7.88TCr 3,34900Cr | EV / Sales 2026 * |
3.61x | EV / Sales 2027 * | 3.14x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INCY | Delayed | |
CBOE
| INCY | Real-time | |
|
Mexican S.E.
| INCY * | End-of-day quote | |
|
Tradegate
| ICY | Real-time | |
|
Berne S.E.
| ICY | End-of-day quote | |
|
Xetra
| ICY | Delayed | |
|
Börse Stuttgart
| ICY | Delayed | |
|
Boerse Muenchen
| ICY | Real-time | |
|
Deutsche Boerse AG
| ICY | Delayed | |
|
Borsa Italiana
| 1INCY | End-of-day quote |
Last Transcript : Incyte Corporation
| 1 day | -0.98% | ||
| 1 week | +1.91% | ||
| Current month | +2.86% | ||
| 1 month | +7.07% | ||
| 3 months | +23.80% | ||
| 6 months | +32.11% | ||
| Current year | +28.33% |
| 1 week | 122.5 |  | 130 |
| 1 month | 117.56 | | 130.8 |
| Current year | 89.25 | | 132.6 |
| 1 year | 81.09 | | 132.6 |
| 3 years | 50.27 | | 132.6 |
| 5 years | 50.27 | | 132.6 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 04/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Tax | EVP, Human Resources | -504 | 0.0002% | ||
| 19/08/26 | Sell | Chairperson | -10,801 | 0.0053% | ||
| 12/08/26 | Sell | Chairperson | -10,803 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | +1.91% | +46.30% | +100.59% | 2.57TCr | |
| -1.87% | +4.22% | +44.36% | +1.14% | 8.27TCr | |
| -0.76% | +0.94% | -18.84% | -35.43% | 6.02TCr | |
| -2.23% | +5.48% | +478.96% | +34.47% | 5.81TCr | |
| -2.03% | -2.62% | -8.63% | +29.27% | 4.97TCr | |
| +0.71% | -1.53% | +0.76% | +155.92% | 4.67TCr | |
| -1.64% | +1.07% | +56.98% | -16.26% | 3.26TCr | |
| -1.07% | -2.41% | +0.80% | +186.56% | 2.27TCr | |
| -0.46% | +0.76% | +64.20% | +106.19% | 1.65TCr | |
| +1.94% | -9.84% | -21.13% | +784.55% | 1.49TCr | |
| Average | -0.84% | -0.68% | +64.38% | +134.70% | 4.1TCr | |
| Weighted average by Cap. | -1.18% | +0.55% | +82.43% | +69.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 594.19Cr 511.3Cr 481.07Cr 439.45Cr 822.09Cr 56TCr 824.33Cr 5.68TCr 2.21TCr 29TCr 2.23TCr 2.18TCr 93TCr | 626.5Cr 539.1Cr 507.22Cr 463.35Cr 866.78Cr 59TCr 869.14Cr 5.99TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 98TCr |
| Net income | 47Cr 40Cr 38Cr 34Cr 64Cr 4.4TCr 65Cr 445.66Cr 172.94Cr 2.26TCr 174.92Cr 171.11Cr 7.27TCr | 149.59Cr 128.72Cr 121.11Cr 110.63Cr 206.96Cr 14TCr 207.52Cr 1.43TCr 555.32Cr 7.25TCr 561.71Cr 549.46Cr 23TCr |
| Net Debt | -422.97Cr -363.96Cr -342.44Cr -312.82Cr -585.19Cr -40TCr -586.78Cr -4.05TCr -1.57TCr -20TCr -1.59TCr -1.55TCr -66TCr | -599.09Cr -515.52Cr -485.03Cr -443.07Cr -828.86Cr -57TCr -831.12Cr -5.73TCr -2.22TCr -29TCr -2.25TCr -2.2TCr -93TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $126.75 | -0.98% | 10,36,073 |
| 03/26/03 | $128.00 | -0.64% | 9,10,226 |
| 02/26/02 | $128.83 | +3.06% | 23,24,205 |
| 01/26/01 | $125.01 | +1.45% | 11,91,993 |
| 31/26/31 | $123.22 | -0.92% | 14,83,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
